The installation spans 16 acres and is expected to generate 3,950 MWh of renewable energy each year. Under a Power Purchase Agreement with solar developer Alight, the behind-the-meter setup will cover approximately 22% of the site’s power requirements. This shift is projected to offset 20,000 tonnes of carbon dioxide equivalent over the next 25 years.
In section Releases
Piramal Pharma to Power Morpeth UK Facility with Solar Array
Piramal Pharma Solutions is moving to cut its carbon footprint by installing a 4.3 MWp solar power plant at its manufacturing site in Morpeth, UK. The project, slated for completion in early 2027, will leverage 6,200 solar panels to provide nearly a quarter of the facility's annual electricity demand.
Frank Bugg, Senior Vice President of UK & Europe Operations, stated that the initiative aligns with the company’s broader strategy to reduce Scope 1 and Scope 2 emissions by 42% by 2030. Rob Stait, Managing Director at Alight, noted that the collaboration serves as a practical model for industrial sites seeking to stabilize energy costs while simultaneously strengthening grid resilience.
Comments (0)
No comments yet. Be the first!